scholarly article | Q13442814 |
P50 | author | Nils Welsh | Q59691737 |
P2093 | author name string | Xuan Wang | |
Per-Ola Carlsson | |||
Per Wikström | |||
Erik Walum | |||
Andris Elksnis | |||
P2860 | cites work | Expression of NADPH oxidase in human pancreatic islets. | Q54299839 |
Antioxidative effects of phenylethanoids from Cistanche deserticola | Q71976537 | ||
Sodium palmitate induces partial mitochondrial uncoupling and reactive oxygen species in rat pancreatic islets in vitro | Q78086387 | ||
Roles of Reactive Oxygen Species on Insulin Resistance in Adipose Tissue | Q26746340 | ||
Evolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target Engagement | Q26861119 | ||
NADPH oxidase (NOX) isoforms are inhibited by celastrol with a dual mode of action | Q30155581 | ||
Islet endothelial activation and oxidative stress gene expression is reduced by IL-1Ra treatment in the type 2 diabetic GK rat | Q33501717 | ||
A novel and specific NADPH oxidase-1 (Nox1) small-molecule inhibitor blocks the formation of functional invadopodia in human colon cancer cells | Q33660799 | ||
Free fatty acids and pathogenesis of type 2 diabetes mellitus | Q34066567 | ||
Cytokines suppress human islet function irrespective of their effects on nitric oxide generation | Q34143253 | ||
Integration of pro-inflammatory cytokines, 12-lipoxygenase and NOX-1 in pancreatic islet beta cell dysfunction | Q34268169 | ||
Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? | Q35034481 | ||
Increased phagocyte-like NADPH oxidase and ROS generation in type 2 diabetic ZDF rat and human islets: role of Rac1-JNK1/2 signaling pathway in mitochondrial dysregulation in the diabetic islet | Q35404856 | ||
The ACE2/Ang-(1-7)/Mas Axis Regulates the Development of Pancreatic Endocrine Cells in Mouse Embryos | Q35647604 | ||
Discovery of GSK2795039, a Novel Small Molecule NADPH Oxidase 2 Inhibitor | Q35984159 | ||
Oxidative stress and impaired insulin secretion in type 2 diabetes | Q36625437 | ||
Nox4 NAD(P)H oxidase mediates Src-dependent tyrosine phosphorylation of PDK-1 in response to angiotensin II: role in mesangial cell hypertrophy and fibronectin expression | Q36855830 | ||
Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity | Q36856230 | ||
NOX family NADPH oxidases in liver and in pancreatic islets: a role in the metabolic syndrome and diabetes? | Q37269522 | ||
NOX4-dependent fatty acid oxidation promotes NLRP3 inflammasome activation in macrophages | Q37548406 | ||
Src tyrosine kinase mediates platelet-derived growth factor BB-induced and redox-dependent migration in metanephric mesenchymal cells | Q37579198 | ||
Increased concentration of iodide in airway secretions is associated with reduced respiratory syncytial virus disease severity | Q37596130 | ||
NOX4 downregulation leads to senescence of human vascular smooth muscle cells. | Q37687002 | ||
Type 2 diabetes mellitus: a metabolic autoinflammatory disease | Q38119302 | ||
A genetically engineered human pancreatic β cell line exhibiting glucose-inducible insulin secretion | Q38271856 | ||
The human Nox4: gene, structure, physiological function and pathological significance | Q38464231 | ||
Role of the AMP kinase in cytokine-induced human EndoC-βH1 cell death | Q38849033 | ||
Palmitate induces reactive oxygen species production and β-cell dysfunction by activating nicotinamide adenine dinucleotide phosphate oxidase through Src signaling | Q39719190 | ||
Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers | Q40081558 | ||
Expression of isoforms of NADPH oxidase components in rat pancreatic islets | Q40231191 | ||
Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic beta-cells | Q40683693 | ||
NOX4 functions as a mitochondrial energetic sensor coupling cancer metabolic reprogramming to drug resistance | Q42380553 | ||
Rational design of small molecule inhibitors targeting the Rac GTPase-p67(phox) signaling axis in inflammation. | Q42609911 | ||
Pancreatic beta-cells express phagocyte-like NAD(P)H oxidase | Q44453013 | ||
ROS-induced ROS release orchestrated by Nox4, Nox2, and mitochondria in VEGF signaling and angiogenesis | Q46380661 | ||
NADPH Oxidase-Dependent Reactive Oxygen Species Stimulate β-Cell Regeneration Through Differentiation of Endocrine Progenitors in Murine Pancreas | Q46655021 | ||
The novel NADPH oxidase 4 inhibitor GLX351322 counteracts glucose intolerance in high-fat diet-treated C57BL/6 mice | Q46708553 | ||
EndoC-βH1 cells display increased sensitivity to sodium palmitate when cultured in DMEM/F12 medium. | Q48144907 | ||
NADPH oxidase-2 does not contribute to β-cell glucotoxicity in cultured pancreatic islets from C57BL/6J mice. | Q50219280 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cell death | Q2383867 |
P304 | page(s) | e0204271 | |
P577 | publication date | 2018-01-01 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | The novel NADPH oxidase 4 selective inhibitor GLX7013114 counteracts human islet cell death in vitro | |
P478 | volume | 13 |
Q90260794 | GPCRs, G Proteins, and Their Impact on β-cell Function |
Q64264027 | Heterogeneity of Metabolic Defects in Type 2 Diabetes and Its Relation to Reactive Oxygen Species and Alterations in Beta-Cell Mass |
Q89487277 | Inhibiting the Activity of NADPH Oxidase in Cancer |
Q90576094 | NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets |
Q96111449 | NADPH oxidases: Current aspects and tools |
Q92079223 | Pharmacological characterization of the seven human NOX isoforms and their inhibitors |
Q99579274 | The pandemic COVID-19: a tale of viremia, cellular oxidation and immune dysfunction |
Search more.